No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine
receptor-binding tracer for positron emission tomography
Source: Int J Rad Appl Instrum B
1986;13(6):617-624.
Author: Satyamurthy N;Bida GT;Barrio JR;Luxen A;Mazziotta JC;Huang
SC;Phelps ME PubMed ID: 3494003
Abstract:
No-carrier-added (NCA)3-(2'-[18F]fluoroethyl)spiperone (5), a new
dopamine receptor-binding radiopharmaceutical for positron emission
tomography, was synthesized by two different methods. Alkylation of the
amide nitrogen in spiperone by NCA [18F]fluorobromoethane in the
presence of a strong base gave 5 (Method A). Experimental methods were
also developed for the syntheses of functional 3-N-alkylderivatives of
spiperone such as 3-(2'-bromoethyl)- or 3-(2'-
methylsulfonyloxyethyl)spiperone (4a and 4b, respectively). These
derivatives (4) reacted with NCA Ag18F, Cs18F or K18F/Kryptofix 222 in
acetonitrile or DMSO to give 5 (Method B). Method B, using
K18F/Kryptofix 222 in acetonitrile provided 5 in multimillicure amounts
(30-40% isolated radiochemical yield) with a specific activity of 2-
10/mumol (EOS) in less than 60 min. This one-step, one-pot synthesis is
simple, and the high radiochemical yield of 5, as well as the 110 min
half-life of 18F, permit multiple tomographic studies a day with one
preparation. Tomographic results in monkey brain with 5 are consistent
with the labeling of dopamine-D2 receptor systems